4//SEC Filing
Freitag Gregory Gene 4
Accession 0001641172-25-019724
CIK 0001859007other
Filed
Jul 14, 8:00 PM ET
Accepted
Jul 15, 4:22 PM ET
Size
5.6 KB
Accession
0001641172-25-019724
Insider Transaction Report
Form 4
Freitag Gregory Gene
Director
Transactions
- Award
Stock Options
2025-07-11+11,066→ 11,066 totalExercise: $0.59Exp: 2035-07-11→ Common Stock (11,066 underlying)
Footnotes (1)
- [F1]The options were granted on July 11, 2025, and vest and become exercisable in equal annual installments on the first three anniversaries of the grant date, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
ZyVersa Therapeutics, Inc.
CIK 0001859007
Entity typeother
Related Parties
1- filerCIK 0001492710
Filing Metadata
- Form type
- 4
- Filed
- Jul 14, 8:00 PM ET
- Accepted
- Jul 15, 4:22 PM ET
- Size
- 5.6 KB